Angiogenic role of miR-20a in breast cancer
Author:
Funder
Instituto de Salud Carlos III
Fundación Salud 2000
Ministerio de Educación, Cultura y Deporte
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference42 articles.
1. Breast cancer;N Harbeck;Lancet,2017
2. Autocrine functions of VEGF in breast tumor cells;M Perrot-Applanat;Cell Adh Migr,2012
3. High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer;S Ghosh;Hum Pathol,2008
4. Lopes G de L, Lima JP da SN. VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis;Cruz MR Santos LV dos;Breast Cancer Res Treat,2015
5. First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients;DW Miles;Ann Oncol,2013
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs);Current Molecular Pharmacology;2023-12
2. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer;International Journal of Molecular Sciences;2023-06-10
3. Non-coding RNA’s prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer;Functional & Integrative Genomics;2023-06
4. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment;Aging;2023-05-12
5. LINC01140 Hinders the Development of Breast Cancer Through Targeting miR-200b-3p to Downregulate DMD;Cell Transplantation;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3